BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market
BWX Technologies, Inc. (NYSE: BWXT) announced an investment to expand its Cambridge manufacturing plant.
BWXT Canada Joins Canadians for CANDU® Campaign
BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT), has joined the Canadians for CANDU Campaign.
BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology
(OTTAWA, Ontario – November 16, 2023) – BWXT Medical Ltd. and Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) today announced that the companies have entered into an agreement for the supply of generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
Scott Gray Appointed Executive Vice President, Project & Field Services for Commercial Operations
(CAMBRIDGE, ON. – March 30, 2022) – BWX Technologies, Inc. (NYSE: BWXT) today announced that it has named Scott Gray to the position of Executive Vice President of Projects & Field Services for BWXT’s Commercial Operations segment (BWXT) effective April 1, 2022.
BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225
(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies (TRTs) and other innovative products.
BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power
BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers.
BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific
(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company.
BWXT Renames Laker Energy Products to BWXT Precision Manufacturing
(OAKVILLE, ON – March 16, 2021) – BWXT Canada Ltd. announced today that it has renamed its subsidiary Laker Energy Products Ltd. to BWXT Precision Manufacturing Inc.
BWXT Names Nuclear Medicine Business as BWXT Medical
(LYNCHBURG, Va. – Feb. 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company, has been renamed BWXT Medical Ltd. (BWXT Medical), in order to better align with the company’s products, customer base and strategy.